康莱特注射液对晚期肺癌患者免疫功能和生活质量的影响

康莱特注射液对晚期肺癌患者免疫功能和生活质量的影响
张东兴;卢宜民
【期刊名称】《现代肿瘤医学》
【年(卷),期】2012(020)008
【摘要】Objective:To observe the effect of Kanglaite injection on immune function and quality of life of patients with advanced lung cancer. Methods: To treat 34 patients with advanced lung cancer by Kanglaite injection. E-valuate the changes of the subgroups of lymphocytes CD3+ , CD4+ ,
CD8+ , CD56+ before treatments and after two cycles of treatments. Results: After treatments, the CD3+ , CD4+ of 34 patients increased obviously. There was significant difference between the data before and after treatments. The number of CD8+ decreased and the number of increased slightly. There was no significant differences of the results. The quality of life of the patients improved in 27 cases (79.41% ), 9 cases improved by 10 scores(26. 47% ) ,10 cases improved by 20 scores(29.
41% ) ,and 8 cases improved by 30 scores (23.53% ) , 4 cases were stable (11.76%). The quality of life went down in 3 cases (8.82% ). Conclusion: Kanglaite injection can improve the immune function and quality of life of patients with advanced lung cancer.%目的:观察康莱特注射液对晚期肺癌患者免疫功能和生活质量的影响.方法:应用康莱特注射液治疗34例晚期肺癌患者,治疗前和治疗2疗程后分别评价患者淋巴细胞亚群CD3+、CD4+、CD8+、CD56+的变化.结果:34例晚期肺癌患者治疗后CD3+、CD4+明显增加,经t检验有显著性差
异；CD8+减少,CD56+稍增加,无显著性差异.生活质量改善:27例(79.41％).提高10分者9例(26.47％)；提高20分者10例(29.41％)；提高30分者8例(23.53％).稳定:4例(11.76％).减退:3例(8.82％).结论:晚期肺癌应用康莱特注射液可以增强免疫力,提高生活质量.
【总页数】2页(P1621-1622)
【作者】张东兴;卢宜民
【作者单位】浙江衢化医院肿瘤科,浙江衢州324004;广州中医药大学祈福医院热疗中心,广东广州511495
【正文语种】中文
【中图分类】R734.2
【相关文献】
1.康莱特注射液对晚期肺癌患者免疫功能影响的研究 [J], 张汀荣;陆向东;张瑶;赵韬;赵臻;潘宇凯
2.康莱特注射液对晚期恶性肿瘤患者生活质量及免疫功能影响的临床观察 [J], 杨晓玲
3.康莱特注射液联合吉非替尼对晚期肺癌患者炎性因子与免疫功能的影响 [J], 金建江;胡启擂;邱滔
4.康莱特注射液对晚期肺癌患者免疫功能影响的研究 [J], 张汀荣;陆向东;张瑶;赵韬;赵臻;潘宇凯;
5.康莱特注射液对乳腺癌新辅助化疗患者免疫功能、血管内皮生长因子及生活质量的影响 [J], 张栓宝; 张燕平; 严宁娟
因版权原因，仅展示原文概要，查看原文内容请购买。